131 related articles for article (PubMed ID: 18416740)
21. Population analysis of CD4+ T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses.
Chiu BC; Shang XZ; Stolberg VR; Komuniecki E; Chensue SW
J Leukoc Biol; 2002 Aug; 72(2):363-72. PubMed ID: 12149428
[TBL] [Abstract][Full Text] [Related]
22. Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium.
Aarvak T; Chabaud M; Källberg E; Miossec P; Natvig JB
Scand J Immunol; 1999 Jul; 50(1):1-9. PubMed ID: 10404044
[TBL] [Abstract][Full Text] [Related]
23. A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.
Nath DS; Tiriveedhi V; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
Transplantation; 2011 May; 91(9):1036-43. PubMed ID: 21383658
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry.
Stinn JL; Taylor MK; Becker G; Nagano H; Hasegawa S; Furakawa Y; Shimizu K; Libby P; Mitchell RN
Am J Pathol; 1998 Nov; 153(5):1383-92. PubMed ID: 9811329
[TBL] [Abstract][Full Text] [Related]
25. Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells.
Colantonio L; Recalde H; Sinigaglia F; D'Ambrosio D
Eur J Immunol; 2002 May; 32(5):1264-73. PubMed ID: 11981813
[TBL] [Abstract][Full Text] [Related]
26. The role of MIG/CXCL9 in cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Whiting D; Irie Y; Fishbein MC; Burdick MD; Belperio J; Strieter RM; Laks H; Berliner JA; Ardehali A
Am J Pathol; 2002 Oct; 161(4):1307-13. PubMed ID: 12368204
[TBL] [Abstract][Full Text] [Related]
27. Expression of Th1/Th2 cell-related chemokine receptors on CD4
Watanabe S; Yamada Y; Murakami H
Int J Lab Hematol; 2020 Feb; 42(1):68-76. PubMed ID: 31825162
[TBL] [Abstract][Full Text] [Related]
28. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.
Burns WR; Wang Y; Tang PC; Ranjbaran H; Iakimov A; Kim J; Cuffy M; Bai Y; Pober JS; Tellides G
Am J Transplant; 2005 Jun; 5(6):1226-36. PubMed ID: 15888026
[TBL] [Abstract][Full Text] [Related]
29. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation.
Sundrud MS; Grill SM; Ni D; Nagata K; Alkan SS; Subramaniam A; Unutmaz D
J Immunol; 2003 Oct; 171(7):3542-9. PubMed ID: 14500650
[TBL] [Abstract][Full Text] [Related]
30. Intimal fibrosis in human cardiac allograft vasculopathy.
Huibers M; De Jonge N; Van Kuik J; Koning ES; Van Wichen D; Dullens H; Schipper M; De Weger R
Transpl Immunol; 2011 Sep; 25(2-3):124-32. PubMed ID: 21782945
[TBL] [Abstract][Full Text] [Related]
31. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
[TBL] [Abstract][Full Text] [Related]
32. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation.
Yin H; Li XY; Jin XB; Zhang BB; Gong Q; Yang H; Zheng F; Gong FL; Zhu JY
Transplantation; 2010 May; 89(10):1189-97. PubMed ID: 20220570
[TBL] [Abstract][Full Text] [Related]
33. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
[TBL] [Abstract][Full Text] [Related]
34. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
35. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
37. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Karni A; Balashov K; Hancock WW; Bharanidharan P; Abraham M; Khoury SJ; Weiner HL
J Neuroimmunol; 2004 Jan; 146(1-2):189-98. PubMed ID: 14698862
[TBL] [Abstract][Full Text] [Related]
38. Expression of Th1/Th2 cytokine mRNA in peritoneal exudative polymorphonuclear neutrophils and their effects on mononuclear cell Th1/Th2 cytokine production in MRL-lpr/lpr mice.
Yu C; Sun K; Tsai C; Tsai Y; Tsai S; Huang D; Han S; Yu H
Immunology; 1998 Nov; 95(3):480-7. PubMed ID: 9824514
[TBL] [Abstract][Full Text] [Related]
39. Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
Aso Y; Matsuura H; Momobayashi A; Inukai Y; Sugawara N; Nakano T; Yamamoto R; Wakabayashi S; Takebayashi K; Inukai T
Endocr J; 2006 Jun; 53(3):377-85. PubMed ID: 16717396
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
